EXORPHIA
EXORPHIA is a biotech startup that develops novel medicine using extracellular vesicles. It engages in the research and development, manufacture, and sale of human cell-derived exosome drugs. EXORPHIA was founded in May 2019 at Nihonbashi Honcho, Chuo-Ku, Tokyo.
EXORPHIA
Social Links:
Industry:
Biotechnology Manufacturing Product Research
Founded:
2019-05-01
Address:
Otemachi, Tokyo, Japan
Country:
Japan
Website Url:
http://www.exorphia.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt WordPress Nginx Google Apps For Business ReCAPTCHA Facebook Sharer ReCAPTCHA V2
Similar Organizations
Bioneer
Bioneer is a biotech company that develops molecular biology products and technologies.
Current Employees Featured
Official Site Inspections
http://www.exorphia.com Semrush global rank: 1.6 M Semrush visits lastest month: 15.94 K
- Host name: www1075.onamae.ne.jp
- IP address: 160.251.148.153
- Location: Tokyo Japan
- Latitude: 35.6882
- Longitude: 139.7532
- Timezone: Asia/Tokyo
- Postal: 102-0082
More informations about "EXORPHIA"
Business | EXORPHIA, INC.
EXORPHIA, INC. Business Description R&D, manufacturing, and sales of exosome-based therapeutics derived from human cells. Location Head Office and Lab: Inspired.Lab, 6th Floor, …See details»
株式会社EXORPHIA（エクソーフィア）
2025.03.21 求人 採用ページの求人情報を更新いたしました; 2025.02.27 お知らせ エクソソーム創薬のexorphia（エクソーフィア）、第9回 j-tech startup summitにて「日本能率協会 産 …See details»
EXORPHIA - Crunchbase Company Profile & Funding
Organization. EXORPHIA . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... EXORPHIA is a biotech startup that develops novel medicine …See details»
Protecting Health with Nature’s Drug Delivery Systems
2024.05.23 NEWS RELEASE EXORPHIA partners with Kyoritsu Holdings and Kyoritsu Seiyaku to jointly develop exosome-based therapeutics for pets 2024.05.23 NEWS RELEASE EXORPHIA Receives Positive Feedback from …See details»
EXORPHIA, INC. - LinkedIn
EXORPHIA is a drug discovery startup that focuses on the potential of exosomes as new treatment options for intractable diseases. The company has developed proprietary core …See details»
Exorphia Company Profile | Management and Employees List
Since its start-up in 2019, EXORPHIA has conducted independent research to develop the INPACT-EV platform technology to purify and concentrate exosomes and characterize them. …See details»
EXORPHIA 2025 Company Profile: Valuation, Funding & Investors
EXORPHIA General Information Description. Developer of novel therapies designed to treat intractable diseases. The company engages in the research and development and sale of …See details»
EXORPHIA - VentureRadar
Find out more about EXORPHIA including the VentureRadar Innovation and Growth scores, Similar Companies and more. All; Ranked; Organisation Names; Apps and Links. Homepage …See details»
EXORPHIA - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jan 13, 2025 EXORPHIA is a biotech startup that develops novel medicine using extracellular vesicles. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
EXORPHIA - Products, Competitors, Financials, Employees, …
EXORPHIA is a drug discovery company, specializing in the development of exosome-based therapies for intractable diseases within the biopharmaceutical sector. The company offers a …See details»
EXORPHIA - Contacts, Employees, Board Members, Advisors
EXORPHIA is a biotech startup that develops novel medicine using extracellular vesicles. New. Resources. Advanced Search. ... Experience the new Crunchbase, powered by AI . …See details»
Leadership team | EXORPHIA, INC.
He served as the founding CEO of two of these companies (Cyfuse Biomedical (TSE: 4892) and EXORPHIA) and as a Director and Executive Officer at the other (ReproCell (TSE:4978)). He …See details»
EXORPHIA USA INC. :: California (US) :: OpenCorporates
EXORPHIA USA INC. Company Number 4750782 Previous Company Numbers. C4750782; Status Active Incorporation Date 2 June 2021 (over 1 year ago) Company Type Stock Corporation - CA - General Jurisdiction California (US) Agent Name YOSHIYUKI TAKI Agent Address 1300 QUALI STREET, SUITE 107, NEWPORT BEACH, CA, 92660See details»
EXORPHIA - Company Profile - Tracxn
Jan 13, 2025 Corporates and Startups. Corp Dev and M&A Teams Corporate Innovation Startup Founders Sales Team. EcosystemSee details»
株式会社EXORPHIA （東京都） | 会社・組織情報ならコープス
株式会社EXORPHIAに関するインターネット上の情報を調査・掲載しています。株式会社EXORPHIAは、東京都千代田区大手町1丁目6番1号大手町ビル6階Inspired．Labに所在する組織です。See details»
Technology | EXORPHIA, INC.
EXORPHIA leverages its proprietary cell activation, EV modification, purification, and analysis technologies to build a robust pipeline targeting various diseases. ... We are currently …See details»
EXORPHIA | VentureRadar
Website: https://exorphia.com/ Develops innovative exosome-based treatments for intractable diseases using a proprietary technology, INPACT-EV®, to concentrate and ...See details»
（プレスリリース）エクソソーム創薬のEXORPHIA（エクソー …
Feb 26, 2025 （プレスリリース）エクソソーム創薬のexorphia（エクソーフィア）、第9回j-tech startup summitにて「日本能率協会 産業振興賞」を受賞 2025年02月26日 15時06分 PR TIMESSee details»
Ryohei Takimoto - Exorphia - ZoomInfo
Otemachi1-6-1 otemachi building 6f 668, Otemachi, Tokyo, 100-0004, Japan. Number of Employees. 5See details»
EXORPHIA - Crunchbase
EXORPHIA is a biotech startup that develops novel medicine using extracellular vesicles.See details»